Philippa Dudley

409 total citations
5 papers, 154 citations indexed

About

Philippa Dudley is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philippa Dudley has authored 5 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Philippa Dudley's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Angiogenesis and VEGF in Cancer (1 paper). Philippa Dudley is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Angiogenesis and VEGF in Cancer (1 paper). Philippa Dudley collaborates with scholars based in United Kingdom, Japan and United States. Philippa Dudley's co-authors include Neil H. James, Juliane M. Jürgensmeier, Sue Ashton, Donald Ogilvie, Charles L. Farnsworth, Stephen R. Wedge, Masabumi Shibuya, Claire H. Barnes, Laurent Hennequin and Anna Wainwright and has published in prestigious journals such as Oncogene, Molecular Cancer Therapeutics and European Journal of Cancer Supplements.

In The Last Decade

Philippa Dudley

5 papers receiving 152 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippa Dudley United Kingdom	4	100	46	42	36	27	5	154
Claire H. Barnes Singapore	2	86 0.9×	55 1.2×	38 0.9×	35 1.0×	19 0.7×	2	137
Ricardo Martínez United States	8	141 1.4×	103 2.2×	27 0.6×	52 1.4×	25 0.9×	15	235
Candace Shelton United States	5	136 1.4×	36 0.8×	16 0.4×	35 1.0×	44 1.6×	5	161
Amanda J. Loch Canada	4	135 1.4×	89 1.9×	44 1.0×	63 1.8×	22 0.8×	5	210
Louise D. Johnson United Kingdom	3	154 1.5×	55 1.2×	37 0.9×	47 1.3×	30 1.1×	4	215
Jaclyn Hearnden United States	3	180 1.8×	54 1.2×	37 0.9×	21 0.6×	17 0.6×	4	234
K Gugała Poland	5	112 1.1×	116 2.5×	36 0.9×	21 0.6×	22 0.8×	9	201
Mike R. Zou United States	5	327 3.3×	69 1.5×	61 1.5×	40 1.1×	15 0.6×	5	373
Morgan Taylor United States	2	113 1.1×	68 1.5×	34 0.8×	19 0.5×	17 0.6×	4	199
Desam Roda United Kingdom	5	81 0.8×	66 1.4×	44 1.0×	29 0.8×	16 0.6×	5	152

Countries citing papers authored by Philippa Dudley

Since Specialization

Citations

This map shows the geographic impact of Philippa Dudley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippa Dudley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippa Dudley more than expected).

Fields of papers citing papers by Philippa Dudley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippa Dudley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippa Dudley. The network helps show where Philippa Dudley may publish in the future.

Co-authorship network of co-authors of Philippa Dudley

This figure shows the co-authorship network connecting the top 25 collaborators of Philippa Dudley. A scholar is included among the top collaborators of Philippa Dudley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippa Dudley. Philippa Dudley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Trinidad, Antonio G., Nicky Whalley, Rachel Rowlinson, et al.. (2017). Pyruvate dehydrogenase kinase 4 exhibits a novel role in the activation of mutant KRAS, regulating cell growth in lung and colorectal tumour cells. Oncogene. 36(44). 6164–6176. 23 indexed citations

2.

Davies, Barry R., Armelle Logié, Claire Crafter, et al.. (2015). Tumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors. Molecular Cancer Therapeutics. 14(11). 2441–2451. 54 indexed citations

3.

Brave, Sandra R., Kirsty Ratcliffe, Zena Wilson, et al.. (2011). Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family. Molecular Cancer Therapeutics. 10(5). 861–873. 72 indexed citations

4.

Davies, Barry R., Philippa Dudley, Sabina Cosulich, et al.. (2009). Abstract C208: CCT129254 (AT11854) is a well tolerated, orally bioavailable inhibitor of AKT/PKB with pharmacodynamic and antitumor activity in a range of xenograft models. Molecular Cancer Therapeutics. 8(12_Supplement). C208–C208. 3 indexed citations

5.

Davies, Barry R., Christine M. Chresta, Philippa Dudley, et al.. (2008). 319 POSTER Pharmacodynamics and anti-tumour activity of KU-0063794, a potent and specific inhibitor of mTOR kinase. European Journal of Cancer Supplements. 6(12). 102–102. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact